Supplementary Table 1 from <i>PIK3CA</i> Mutation H1047R Is Associated with Response to PI3K/AKT/mTOR Signaling Pathway Inhibitors in Early-Phase Clinical Trials

crossref(2023)

引用 0|浏览0
暂无评分
摘要

PDF file - 46K, Therapies targeting PI3K/AKT/mTOR pathway

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要